Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns methods for inhibition of STAT biological functions using platinum complexes.

Abstract: The subject invention concerns methods for inhibition of STAT biological functions using platinum complexes.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: Several compositions of matter have been discovered that can be used in the manufacture of slow-release fertilizers that contain all of the essential elements needed by plants and humans. Slow-release fertilizers manufactured with these formulations can be used on mineral stressed soils to increase the quality and production of food crops grown on them. Additives, including phosphogypsum, silica sand, natural gypsum, clay, and coal dust, facilitate the timing of the release of the essential elements into the soil.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns methods for inhibition of STAT biological functions using platinum complexes.

Abstract: The subject invention concerns methods for inhibition of STAT biological functions using platinum complexes.

Abstract: Several compositions of matter have been discovered that can be used in the manufacture of slow-release fertilizers that contain all of the essential elements needed by plants and humans. Slow-release fertilizers manufactured with these formulations can be used on mineral stressed soils to increase the quality and production of food crops grown on them.

Abstract: The present invention discloses (mono)ethylenediaminenitroplatinum (IV) complexes of with ligands of oxides of nitrogen, and their synthesis, which, in vivo, may be reduced to produce "cisplatin" type platinum(II) antitumor complex and nitric oxide, which also reportedly has anti-tumor activity.

Abstract: Gingivitis and related periodontal problems of the gingival tissues may be treated with a dental hygiene composition comprising an effective amount of a calcium sulfate compound such as calcium sulfate hemihydrate. Preferred compositions comprise mouthwashes and oral rinses containing about 5-90% by weight of calcium sulfate hemihydrate, a liquid carrier such as water, a humectant and an alcohol.

Abstract: This invention relates to the manufacture of hydroxylapatite in a through-solution process wherein monobasic calcium phosphate is reacted with a calcium hydroxide solution. In a preferred embodiment, an acidic premix is formed by reacting phosphoric acid and calcium hydroxide with high shear agitation in a first stage, and thereafter reacting the acidic premix with a saturated solution of calcium hydroxide also under high shear agitation in a second stage. The second stage reaction is carried out in an alkaline solution by carefully metering the acid premix into the calcium hydroxide solution whereby the pH of the solution is maintained above 11 until the reaction is near completion. It is particularly preferred to use a stoichiometric portion of calcium hydroxide in carrying out the reactions. After the hydroxylapatite precipitate is recovered, it may be sintered at a temperature between about 700.degree. C. and 1100.degree. C. for about 5 to 30 minutes to form a crystalline hydroxylapatite.

Abstract: Solidification of colloidal argillaceous matter in essentially non-settling, aqueous slime media into a solid stable matrix is accomplished by mixing such slime with a hydratable calcium sulfate and hydrating to form an interlocking strength bearing matrix. The method is particularly useful for coalescing phosphatic clay slimes with hydratable calcium sulfate prepared from the co-produced waste phosphogypsum.

Abstract: A wet process for producing phosphoric acid and phosphoanhydrite by acidulation of phosphate rock with a phosphoric acid/sulfuric acid mixture containing a very high recycle content of small sized anhydrite seed crystals. A strong phosphoric acid is obtained having a concentration of at least about 35% P.sub.2 O.sub.5. Further, the phosphoanhydrite may be readily converted to an industrially usable gypsum product.

Abstract: A wet process for producing phosphoric acid and phosphohemihydrate by acidulation of phosphate rock. A strong phosphoric acid is obtained with concomitant production of an improved calcium sulfate that is extremely low in radioactivity by operation in Region II for shorter time so as to produce small sized hemihydrate particles, then hydration of a substantial proportion but less than all of the hemihydrate to coarse gypsum substantially free of radioactivity in a dilute acidic aqueous slurry at a temperature and P.sub.2 O.sub.5 concentration selected so as to be within Region I of FIG. 1 and having a substantial weight proportion of coarser gypsum particles that are substantially free of radioactivity.